Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs.

Blum K, Simpatico T, Febo M, Rodriquez C, Dushaj K, Li M, Braverman ER, Demetrovics Z, Oscar-Berman M, Badgaiyan RD.

Mol Neurobiol. 2017 Jul;54(5):3753-3758. doi: 10.1007/s12035-016-9934-y. Epub 2016 May 31.

2.

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.

Blum K, Febo M, Badgaiyan RD, Demetrovics Z, Simpatico T, Fahlke C, M OB, Li M, Dushaj K, Gold MS.

Curr Neuropharmacol. 2017;15(1):184-194. Review.

3.

Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.

McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, Fratantonio JL, Simpatico T, Gold MS.

J Behav Addict. 2015 Jun;4(2):106-15. doi: 10.1556/2006.4.2015.008.

4.

Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.

Blum K, Badgaiyan RD, Agan G, Fratantonio J, Simpatico T, Febo M, Haberstick BC, Smolen A, Gold MS.

J Reward Defic Syndr. 2015;1(1):65-68.

5.

Vermont responds to its opioid crisis.

Simpatico TA.

Prev Med. 2015 Nov;80:10-1. doi: 10.1016/j.ypmed.2015.04.002. Epub 2015 Apr 11.

PMID:
25869219
6.

Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.

Blum K, Simpatico T, Badgaiyan RD, Demetrovics Z, Fratantonio J, Agan G, Febo M, Gold MS.

J Reward Defic Syndr. 2015;1(2):75-80. Epub 2015 Jun 24.

7.

rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.

Blum K, Liu Y, Wang W, Wang Y, Zhang Y, Oscar-Berman M, Smolen A, Febo M, Han D, Simpatico T, Cronjé FJ, Demetrovics Z, Gold MS.

Postgrad Med. 2015 Mar;127(2):232-41. Epub 2014 Dec 16.

8.

Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Blum K, Han D, Femino J, Smith DE, Saunders S, Simpatico T, Schoenthaler SJ, Oscar-Berman M, Gold MS.

PLoS One. 2014 Sep 23;9(9):e104275. doi: 10.1371/journal.pone.0104275. eCollection 2014.

9.

A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain.

Blum K, Oscar-Berman M, Waite RL, Braverman ER, Kreuk F, Li M, Dushaj K, Madigan MA, Hauser M, Simpatico T, Barh D.

J Genet Syndr Gene Ther. 2014 Jan 27;5(1):213. No abstract available.

10.

Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study.

Kushner S, Han D, Oscar-Berman M, William Downs B, Madigan MA, Giordano J, Beley T, Jones S, Barh D, Simpatico T, Dushaj K, Lohmann R, Braverman ER, Schoenthaler S, Ellison D, Blum K.

J Addict Res Ther. 2013 Jul 2;4(3). pii: 153.

11.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

Blum K, Oscar-Berman M, Femino J, Waite RL, Benya L, Giordano J, Borsten J, Downs WB, Braverman ER, Loehmann R, Dushaj K, Han D, Simpatico T, Hauser M, Barh D, McLaughlin T.

J Addict Res Ther. 2013 Apr 23;4(2). doi: 10.4172/2155-6105.1000146.

12.

Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™

Downs B, Oscar-Berman M, Waite R, Madigan M, Giordano J, Beley T, Jones S, Simpatico T, Hauser M, Borsten J, Marcelo F, Braverman E, Lohmann R, Dushaj K, Helman M, Barh D, Schoenthaler S, Han D, Blum K.

J Genet Syndr Gene Ther. 2013 Jun 3;4(136):14318.

13.

Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

Blum K, Oscar-Berman M, Stuller E, Miller D, Giordano J, Morse S, McCormick L, Downs WB, Waite RL, Barh D, Neal D, Braverman ER, Lohmann R, Borsten J, Hauser M, Han D, Liu Y, Helman M, Simpatico T.

J Addict Res Ther. 2012 Nov 27;3(5):139.

14.

Long term Suboxone™ emotional reactivity as measured by automatic detection in speech.

Hill E, Han D, Dumouchel P, Dehak N, Quatieri T, Moehs C, Oscar-Berman M, Giordano J, Simpatico T, Barh D, Blum K.

PLoS One. 2013 Jul 9;8(7):e69043. doi: 10.1371/journal.pone.0069043. Print 2013. Erratum in: PLoS One. 2013;8(8):doi/10.1371/annotation/be0b3a26-c1bc-4d92-98c1-c516acc8dcf2. Barh, Debmalya [added].

15.

Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).

Mclaughlin T, Oscar-Berman M, Simpatico T, Giordano J, Jones S, Barh D, Downs WB, Waite RL, Madigan M, Dushaj K, Lohmann R, Braverman ER, Han D, Blum K.

J Behav Addict. 2013 Jun;2(2):117-24. doi: 10.1556/JBA.2.2013.2.8.

PMID:
26165932
16.

Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms.

Blum K, Oscar-Berman M, Bowirrat A, Giordano J, Madigan M, Braverman ER, Barh D, Hauser M, Borsten J, Simpatico T.

J Genet Syndr Gene Ther. 2012 Apr 13;3(112). pii: 1000112.

17.

Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.

Blum K, Oscar-Berman M, Giordano J, Downs B, Simpatico T, Han D, Femino J.

J Genet Syndr Gene Ther. 2012 Oct 17;3(4). pii: 1000e115.

18.
19.

The addictive brain: all roads lead to dopamine.

Blum K, Chen AL, Giordano J, Borsten J, Chen TJ, Hauser M, Simpatico T, Femino J, Braverman ER, Barh D.

J Psychoactive Drugs. 2012 Apr-Jun;44(2):134-43. Review.

PMID:
22880541
20.

Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Blum K, Chen TJ, Bailey J, Bowirrat A, Femino J, Chen AL, Simpatico T, Morse S, Giordano J, Damle U, Kerner M, Braverman ER, Fornari F, Downs BW, Rector C, Barh D, Oscar-Berman M.

Mol Neurobiol. 2011 Dec;44(3):250-68. doi: 10.1007/s12035-011-8206-0. Epub 2011 Sep 24.

Supplemental Content

Loading ...
Support Center